AI‐Guided Design of pH‐ and Redox‐Responsive Lignin@GO@ZIF‐8 Nanocarriers for Targeted Co‐Delivery of 5‐Fluorouracil and Metformin in Prostate Cancer Therapy
Small · 2026-04 · 22 (19)
DOI: 10.1002/smll.202513085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 02.02.2026. Verfasst von Babbiker Mohammed Taher Gorish und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Laboratory On Synthetic Biology and Biomass Biorefinery, Biofuels Institute, School of Emergency Management, School of the Enviro…. Hauptthemen laut MEDLINE: Fluorouracil, Prostatic Neoplasms, Metformin, Graphite. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Key R&D Program of China, Key Research and Development Program of Jiangsu Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Prostate cancer therapy is limited by systemic toxicity and inefficient tumor‐selective delivery. Here we report a multi‐stimuli‐responsive nanocomposite, Lignin@GO@ZIF‐8, that co‐delivers 5‐Fluorouracil (5‐FU) and metformin and couples pH‐ and redox‐responsive release. We integrate machine learning (ML) to guide formulation: trained on 500 formulation property pairs with cross‐validation and a held‐out test set, XGBoost achieved the highest predictive performance ( R 2 = 0.86–0.89) for drug loading, encapsulation efficiency, and release rate, with influential features including the ZIF‐8 fraction, graphene oxide (GO) content, particle size, zeta potential, pH, and glutathione concentration. ML‐optimized Lignin@GO@ZIF‐8 exhibited improved loading and tunable release relative to pre‐optimized controls. In vitro, the platform sustained drug release and produced potent anticancer activity, reducing LNCaP viability to 18 ± 3% at 72 h, while showing low cytotoxicity toward non‐malignant cells. These results support a data‐driven framework for rational design of multifunctional, stimuli‐responsive nanomedicine platforms and may help inform future translational strategies for prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Joint Laboratory On Synthetic Biology and Biomass Biorefinery, Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, P. R. Chi…
- Jiangsu Collaborative Innovation Center of Technology and Material of Water Treatment, Suzhou University of Science and Technology, Suzhou, P. R. China.
- Department of Microbiology, College of Medical Laboratory Science, Omdurman Islamic University, Khartoum, Sudan.
ORCID-Profile: Daochen Zhu
Förderung
- National Key R&D Program of China
- Key Research and Development Program of Jiangsu Province
- National Key Research and Development Program of China
Zitieren
APA
Gorish, B. M. T., Abdelmula, W. I. Y., Wenqian, D., Yue, B., Yahu, L., & Zhu, D. (2026). AI‐Guided Design of pH‐ and Redox‐Responsive Lignin@GO@ZIF‐8 Nanocarriers for Targeted Co‐Delivery of 5‐Fluorouracil and Metformin in Prostate Cancer Therapy. Small, 22(19). https://doi.org/10.1002/smll.202513085
Vancouver
Gorish BMT, Abdelmula WIY, Wenqian D, Yue B, Yahu L, Zhu D. AI‐Guided Design of pH‐ and Redox‐Responsive Lignin@GO@ZIF‐8 Nanocarriers for Targeted Co‐Delivery of 5‐Fluorouracil and Metformin in Prostate Cancer Therapy. Small. 2026;22(19). doi:10.1002/smll.202513085
BibTeX
@article{Gorish2026,
author = {Gorish, Babbiker Mohammed Taher and Abdelmula, Waha Ismail Yahia and Wenqian, Dang and Yue, Bai and Yahu, Lu and Zhu, Daochen},
title = {AI‐Guided Design of pH‐ and Redox‐Responsive Lignin@GO@ZIF‐8 Nanocarriers for Targeted Co‐Delivery of 5‐Fluorouracil and Metformin in Prostate Cancer Therapy},
journal = {Small},
year = {2026},
volume = {22},
number = {19},
doi = {10.1002/smll.202513085}
}
EUVIMED